BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 16007169)

  • 1. SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition.
    Weber A; Hengge UR; Bardenheuer W; Tischoff I; Sommerer F; Markwarth A; Dietz A; Wittekind C; Tannapfel A
    Oncogene; 2005 Oct; 24(44):6699-708. PubMed ID: 16007169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation of SOCS-3 and SOCS-1 in the carcinogenesis of Barrett's adenocarcinoma.
    Tischoff I; Hengge UR; Vieth M; Ell C; Stolte M; Weber A; Schmidt WE; Tannapfel A
    Gut; 2007 Aug; 56(8):1047-53. PubMed ID: 17376806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
    Lee TL; Yeh J; Van Waes C; Chen Z
    Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma.
    Niwa Y; Kanda H; Shikauchi Y; Saiura A; Matsubara K; Kitagawa T; Yamamoto J; Kubo T; Yoshikawa H
    Oncogene; 2005 Sep; 24(42):6406-17. PubMed ID: 16007195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer.
    He B; You L; Uematsu K; Zang K; Xu Z; Lee AY; Costello JF; McCormick F; Jablons DM
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14133-8. PubMed ID: 14617776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line.
    To KF; Chan MW; Leung WK; Ng EK; Yu J; Bai AH; Lo AW; Chu SH; Tong JH; Lo KW; Sung JJ; Chan FK
    Br J Cancer; 2004 Oct; 91(7):1335-41. PubMed ID: 15354212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of the suppressor of cytokine signaling-3 promoter in human non-small-cell lung cancer.
    He B; You L; Xu Z; Mazieres J; Lee AY; Jablons DM
    Clin Lung Cancer; 2004 May; 5(6):366-70. PubMed ID: 15217536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma.
    Oshimo Y; Kuraoka K; Nakayama H; Kitadai Y; Yoshida K; Chayama K; Yasui W
    Int J Cancer; 2004 Dec; 112(6):1003-9. PubMed ID: 15386345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation-mediated gene silencing of suppressor of cytokine signaling-1 (SOCS-1) gene in esophageal squamous cell carcinoma patients of Kashmir valley.
    Hussain S; Singh N; Salam I; Bandil K; Yuvaraj M; Akbar Bhat M; Muzaffar Mir M; Siddiqi MA; Sobti RC; Bharadwaj M; Das BC
    J Recept Signal Transduct Res; 2011 Apr; 31(2):147-56. PubMed ID: 21385099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential hypermethylation of SOCS genes in ovarian and breast carcinomas.
    Sutherland KD; Lindeman GJ; Choong DY; Wittlin S; Brentzell L; Phillips W; Campbell IG; Visvader JE
    Oncogene; 2004 Oct; 23(46):7726-33. PubMed ID: 15361843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis.
    Okochi O; Hibi K; Sakai M; Inoue S; Takeda S; Kaneko T; Nakao A
    Clin Cancer Res; 2003 Nov; 9(14):5295-8. PubMed ID: 14614012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma.
    Galm O; Yoshikawa H; Esteller M; Osieka R; Herman JG
    Blood; 2003 Apr; 101(7):2784-8. PubMed ID: 12456503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demethylation treatment restores hic1 expression and impairs aggressiveness of head and neck squamous cell carcinoma.
    Brieger J; Pongsapich W; Mann SA; Hedrich J; Fruth K; Pogozelski B; Mann WJ
    Oral Oncol; 2010 Sep; 46(9):678-83. PubMed ID: 20729134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms.
    Fukushima N; Sato N; Sahin F; Su GH; Hruban RH; Goggins M
    Br J Cancer; 2003 Jul; 89(2):338-43. PubMed ID: 12865927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity.
    Yoshikawa H; Matsubara K; Qian GS; Jackson P; Groopman JD; Manning JE; Harris CC; Herman JG
    Nat Genet; 2001 May; 28(1):29-35. PubMed ID: 11326271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of the suppressor of cytokine signalling-1 (SOCS-1) in myelodysplastic syndrome.
    Brakensiek K; Länger F; Schlegelberger B; Kreipe H; Lehmann U
    Br J Haematol; 2005 Jul; 130(2):209-17. PubMed ID: 16029449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: Role in apoptosis induction and radiosensitization in head and neck tumor cells.
    Baek SH; Ko JH; Lee H; Jung J; Kong M; Lee JW; Lee J; Chinnathambi A; Zayed ME; Alharbi SA; Lee SG; Shim BS; Sethi G; Kim SH; Yang WM; Um JY; Ahn KS
    Phytomedicine; 2016 May; 23(5):566-77. PubMed ID: 27064016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.
    Masuda M; Suzui M; Yasumatu R; Nakashima T; Kuratomi Y; Azuma K; Tomita K; Komiyama S; Weinstein IB
    Cancer Res; 2002 Jun; 62(12):3351-5. PubMed ID: 12067972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma.
    Miyoshi H; Fujie H; Moriya K; Shintani Y; Tsutsumi T; Makuuchi M; Kimura S; Koike K
    J Gastroenterol; 2004 Jun; 39(6):563-9. PubMed ID: 15235874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
    Lejeune D; Demoulin JB; Renauld JC
    Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.